Buscar
Mostrando ítems 1-10 de 186
The Polemic Diagnostic Role of TP53 Mutations in Liquid Biopsies from Breast, Colon and Lung Cancers
Being minimally invasive and thus allowing repeated measures over time, liquid biopsies are taking over traditional solid biopsies in certain circumstances such as those for unreachable tumors, very early stages or treatment ...
MicroRNAs as Liquid Biopsy Biomarkers for Early Detection in Lung Cancer.
(Elsevier B.V., 2018-10-01)
Liquid biopsy for T790M detection in patients with non-small cell lung cancer in a public hospital in Corrientes capital
(Fundación Revista Medicina, 2019)
Access limitations to an early diagnosis influences high rates of lung cancer mortality in the northeast region of Argentina. Lack of specialists and equipment plus long distances to medical centers that perform such studies ...
Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy
(Springer Science and Business Media Deutschland GmbH, 2020-10-28)
Immunotherapy has been one of the great advances in the recent years for the treatment of advanced tumors, with nonsmall-cell lung cancer (NSCLC) being one of the cancers that has benefited most from this approach. Currently, ...
Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021
(Elsevier, 2021-05)
Lung cancer is the leading cause of cancer death worldwide, with non-small cell lung cancer (NSCLC) representing its most commonly diagnosed sub-type. Despite the significant improvements in lung cancer biomarkers knowledge, ...
Liquid biopsy as a diagnostic and prognostic tool for women and female dogs with breast cancer
(2021-10-01)
Introduction: Breast cancer (BC) is the malignant neoplasm with the highest mortality rate in women and female dogs are good models to study BC. Objective: We investigated the efficacy of liquid biopsy to detect gene ...
Towards the dreamed biomarkers?
(OMICS International, 2016-04)
Detection and determination of tumor biomarkers are made from tissue and blood collection. During the last decade new biological sources are feasible: circulating tumor cells and circulating nucleic acids. They are composing ...
miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma
(Mdpi, 2021-01-01)
Detecting circulating microRNAs (miRNAs; miRs) by means of liquid biopsy is an important tool for the early diagnosis and prognosis of breast cancer (BC). We aimed to identify and validate miR-210 and miR-152 as non-invasive ...